Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Anti-CD38 immunotherapy treatment for multiple myeloma

Prof Xavier Leleu - CHU de Poitiers, Poitiers, France
Anti-CD38 immunotherapy treatment for multiple myeloma ( Prof Xavier Leleu - CHU de Poitiers, Poitiers, France )
22 Nov 2021

Paediatric ALL perspective

Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy
Paediatric ALL perspective ( Prof Andrea Biondi - University of Milano-Bicocca, Milan, Italy )
12 Nov 2021

Latest in Philadelphia chromosome-positive ALL (Ph+ ALL)

Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Latest in Philadelphia chromosome-positive ALL (Ph+ ALL) ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
11 Nov 2021

OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
26 Oct 2021

WCLC 2021: Epidemiology of MET Exon 14 mutations

Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger
WCLC 2021: Epidemiology of MET Exon 14 mutations ( Dr Anna Minchom, Dr Alex Spira, Prof Byoung Chul Cho and Prof Albrecht Stenzinger )
19 Oct 2021

Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
14 Oct 2021

Welcome to APCCC 2021

Prof Silke Gillessen and Prof Aurelius Omlin
Welcome to APCCC 2021 ( Prof Silke Gillessen and Prof Aurelius Omlin )
23 Sep 2021

OncoAlert and ecancer - ESMO 2021 Day 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer - ESMO 2021 Day 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
21 Sep 2021

OncoAlert and ecancer - ESMO 2021 Day 4

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer - ESMO 2021 Day 4 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
20 Sep 2021

Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer

Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA
Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer ( Prof Bradley Monk - University of Arizona College of Medicine, Phoenix, USA )
18 Sep 2021

6 months trastuzumab non-inferior to 12 months for HER2 positive early breast cancer

Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom
6 months trastuzumab non-inferior to 12 months for HER2 positive early breast cancer ( Prof Helena Earl - University of Cambridge, Cambridge, United Kingdom )
17 Sep 2021

Multidisciplinary management of ovarian germ cell tumours - a single institutional study from India

Dr Sandip Ganguly - Tata Medical Center, Kolkata, India
Multidisciplinary management of ovarian germ cell tumours - a single institutional study from India ( Dr Sandip Ganguly - Tata Medical Center, Kolkata, India )
14 Sep 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation